Clinical Trials Logo

Clinical Trial Summary

Behçet's Disease(BD) is a systemic inflammatory vasculitis, which affects all types and sizes of vessels. Statins display numerous effects often independent of the well-established lipid-lowering effects that may be of benefit in retarding or preventing vascular injury and ischaemic vascular events. The aim of the present study was to determine the efficacy of rosuvastatin in improving vascular dysfunction and vascular inflammation and to assess the effect of rosuvastatin on vascular involvement in BD patients. Fifty-six BD patients (51 males and 5 females) mean age 33.4 years, mean disease duration 5.8 years), all fulfilling the classification criteria of the International Study Group for Behçet's disease were recruited.Patients were randomised into 2 groups.

The first group (n=27: 20 active and 7 inactive) were assigned to receive 40 mg of rosuvastatin and the second group(n=29: 21 active and 8 inactive) received placebo for 12 months. Inflammatory and endothelial dysregulation markers were measured at baseline and after 12 months. All patients were examined for vascular involvement. Venous or arterial system involvement was defined as present when confirmed by Doppler ultrasonography, magnetic resonance angiography, conventional angiography or CT.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04328064
Study type Interventional
Source University of Alexandria
Contact
Status Completed
Phase N/A
Start date May 2010
Completion date June 2011

See also
  Status Clinical Trial Phase
Recruiting NCT05635266 - Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Completed NCT02190916 - Vasculitis Illness Perception (VIP) Study N/A
Completed NCT04065672 - Low-dose IL-2 Treatment on Behcet's Disease Phase 2
Recruiting NCT02593565 - Vasculitis Pregnancy Registry
Completed NCT00167583 - Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet`s Disease (INCYTOB) Phase 3
Completed NCT03371095 - Induction Therapy With Anti-TNFα vs Cyclophosphamide in Severe Behçet Disease Phase 3
Completed NCT01960790 - Special Investigation in Patients With Intestinal Behcet's Disease (All Case Investigation)
Completed NCT03531385 - Assessment of Central Sensitization, Neuropathic Pain, Sleep Quality and Daily Life Activities in Behcet's Disease
Completed NCT02190942 - VCRC Patient Contact Registry Patient-Reported Data Validation Study
Not yet recruiting NCT06285539 - Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases Phase 2
Completed NCT02190929 - Educational Needs of Patients With Systemic Vasculitis N/A
Completed NCT02476292 - Impact of Vasculitis on Employment and Income N/A
Completed NCT03543709 - Evaluation of Fibromyalgia With Disease Activity and Clinical Findings in Women With Behçet's Disease
Recruiting NCT01793168 - Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Completed NCT01988506 - Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases Phase 2
Recruiting NCT01952275 - Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases N/A
Completed NCT01532570 - Clinical Study of TA-650 in Patients With Behcet's Disease (BD) With Special Lesions Phase 3
Completed NCT03410290 - Journey of Patients With Vasculitis From First Symptom to Diagnosis
Completed NCT02176070 - Reproductive Health in Men and Women With Vasculitis N/A
Recruiting NCT01306955 - The Efficacy of Methylprednisolone in the Treatment of Patients With Ocular Involvement in Behcet's Disease Phase 4